# Shared proteomic landscape between arteriosclerosis and cardiovascular endpoints: a Mendelian randomization and observational study integrating AlphaFold3 for structural prediction.

- **DOI:** [10.1093/cvr/cvag095](https://doi.org/10.1093/cvr/cvag095)
- **Rating:** Sound (3.3 out of 5)
- **Verdict:** A competent cross-vascular proteomic prioritization study that adds useful mediation hypotheses, but single-instrument evidence and overextended causal framing limit confidence.
- **Framework version:** v5.9
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-10-08
- **Evaluation page:** https://www.nabu.science/paper/10.1093%2Fcvr%2Fcvag095

## Key claims

1. We prioritized 10 proteins potentially causally associated with both the arteriosclerotic/atherosclerotic markers and cardiovascular events.
   - Support: Supported
   - Type: Primary finding
   - Basis: staged colocalization and cis-MR support prioritization, though many associations rely on single instruments
   - Location: Abstract
2. LPA's effect on stroke was primarily mediated through carotid plaque (92.4%).
   - Support: Tentative
   - Type: Secondary
   - Basis: network-MR mediation lacks reported headline uncertainty and depends on unstated sequential causal assumptions
   - Location: Abstract; Results, Figure 6B
3. limited overlap of potential causal proteins across the studied markers in different vascular beds
   - Support: Supported
   - Type: Secondary
   - Basis: the reported screen found little overlap, although differing phenotype power may contribute
   - Location: Discussion, paragraph 1
4. Structural modelling using AlphaFold3 identified key functional variants in several proteins, including ANGPTL4 and FN1
   - Support: Tentative
   - Type: Secondary
   - Basis: structural visualizations are hypothesis-generating and lack functional validation or reported confidence metrics
   - Location: Abstract; Results, “Structural alterations of 7 proteins predicted by AlphaFold3”

## Strengths

- **Layered causal-prioritization pipeline** The study combines colocalization, cis-pQTL MR, directionality checks, transcriptomic analyses, observational triangulation, and mediation across multiple vascular phenotypes.
  - Dimension: methodological rigour
  - Location: Methods, Figure 1; Results, Figures 2–6
- **Detailed assay-artefact sensitivity work** Missense-linked instruments are cross-referenced against eQTL evidence, removed in sensitivity analyses, and examined in a gene-dense-region analysis that leads to exclusion of ERP29, LTBP4, and FRZB where appropriate.
  - Dimension: methodological rigour
  - Location: Methods, “Proteome-wide Mendelian randomization analysis”; Results, missense-IV and gene-dense-region sections
- **Broad vascular-bed comparison** Five markers and eight cardiovascular outcomes are analyzed to distinguish shared from vascular-bed-specific protein associations, yielding a focused ten-protein set for downstream study.
  - Dimension: contribution
  - Location: Abstract; Results, Figures 2–4

## Limitations

- **Many estimates rely on one instrument** Only 33.3% of candidates had at least three instruments, leaving most estimates without weighted-median or MR-Egger sensitivity analyses and making residual pleiotropy difficult to assess.
  - Dimension: methodological rigour
  - Location: Results, “Potential causal proteins prioritized”; Discussion, “Strengths and limitations”
- **Mediation evidence lacks robust qualification** The headline LPA mediation estimate differs between the Abstract and Results, lacks a reported confidence interval in the main text, and rests on assumptions not explicitly developed in the mediation methods.
  - Dimension: methodological rigour
  - Location: Abstract; Methods, “Network MR and mediation analysis”; Results, Figure 6B
- **Validation and therapeutic language overreaches** Transcriptomic results include missing instruments and opposite-direction findings, while observational support covers only part of the protein set. The Abstract and Conclusions nevertheless describe broad corroboration, causal evidence, and therapeutic promise.
  - Dimension: reporting
  - Location: Abstract; Results, SMR/HEIDI and observational triangulation sections; Conclusions

## Reliability checks

Caveats (4 of 4 checks).

- **Results check:** Noted
  - LPA's effect on stroke was primarily mediated through carotid plaque (92.4%): "Mediation analyses estimated that LPA's effect on stroke was primarily mediated through carotid plaque (92.4%)." (Abstract, Methods and Results) vs "The most prominent mediation effect was the LPA effect on any stroke via carotid plaque (proportion mediated: 92.7%; Figure 6B), followed by its effect on large-artery stroke via carotid plaque (proportion mediated: 42.7%)." (Results, Mediation effect of protein on cardiovascular events via arteriosclerosis and atherosclerosis). The Results estimate exceeds the Abstract estimate by 92.7 − 92.4 = 0.3 percentage points, and both estimates indicate predominantly mediated effects. → Conclusion holds
- **Reporting and transparency:** Noted. The stated mediation formula does not define a proportion, and the SMR FDR inequality leaves its selection threshold unclear; neither establishes that an incorrect analysis was actually performed.
  - Preregistration: not stated · Data availability: declared · Code availability: not stated
- **Reference integrity:** Clean
  - 57 references in manuscript
  - 56 of 56 checkable references found in an index
  - 1 are books, websites or datasets — counted, but not index-checkable
  - Citation details diverge for 1 reference:
    - #39 Johannesen CDL , Langsted A , Nordestgaard BG , Mortensen MB . Excess apolipoprotein B and cardiovascular risk in women and men . J Am Coll Cardiol 2024 ; 83 : 2262 – 2273 . 38839200 10.1016/j.jacc.2024.03.423 (DOI resolves to: “Excess Apolipoprotein B and Cardiovascular Risk in Women and Men” — Johannesen, 2024 (JACC). Differs from the DOI’s record on: container, authors) https://doi.org/10.1016/j.jacc.2024.03.423
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-10-17
